The traditional "golden triangle drugs" (β-receptor blocker, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, aldosterone antagonists) have been the main drugs in clinical treatment of heart failure in the past two decades. The gene discussed is ACE; the disease is heart failure.